Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Monitoring Between Cycles (Pt. 3)

This is the third episode in the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Tune in as the panel explores challenges with patient monitoring, when to dose adjust and hold, or even discontinue, before concluding with a few take home points on side effects. 
   
Moderator:
Tracilyn Hall, MD
2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member, Moderator
 
Speakers:
Jennifer MacDonald, PharmD, BCOP
Kathleen Moore, MD 
Bernard Tawfik, MD  
 

Keywords: Enhertu, Trastuzumab Deruxtecan, Trastuzumab Deruxtecan Enhertu, HER2

Target Audience

SGO Members 

You may also be interested in

Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Preparing to Give It (Pt. 1)
​​​​​This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Tune in as the multidisciplinary panel reviews general information (such as when to use, checking patient performance status, tox
​​​​​This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Tune in as the multidisciplinary panel reviews general information (such as when to use, checking patient performance status, tox
Course summary
Course opens: 
06/27/2024
Course expires: 
06/27/2029
Cost:
$0.00
Rating: 
0

Price

Cost:
$0.00
Please login or register to take this course.

Thank you for listening to this episode.